Canopy Growth Corp CGC

Latest FY: 2026 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $0.98
Market Cap $409.41M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↑5.8% YoY
$284.60M
3-Yr CAGR: -10.9%
Net Income ↑56.0% YoY
-$262.91M
Net Margin: -92.4%
Free Cash Flow ↑60.8% YoY
-$69.14M
FCF Yield: -16.89%
EPS (Diluted) ↑84.2% YoY
$-0.88
Basic: $-0.88
Return on Equity Efficiency
-37.7%
ROA: -23.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CGC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $39.9M $24.6M $-0.1M $-0.06 0.00% $-27.1M $-56.5M
FY 2018 $77.9M +95.4% $40.2M $16.2M +32,538.0% $-0.40 -566.7% 0.00% $-81.5M $-257.5M -356.0%
FY 2019 $226.3M +190.4% $88.9M $15.3M -5.4% $-2.57 -542.5% 0.00% $-520.5M $-1,165.0M -352.3%
FY 2020 $398.8M +76.2% $-31.7M $-1,321.3M -8,711.4% $-3.80 -47.9% 0.00% $-772.6M $-1,477.6M -26.8%
FY 2021 $546.6M +37.1% $67.0M $-1,744.9M -32.1% 0.00% $-465.7M $-630.2M +57.3%
FY 2022 $520.3M -4.8% $-193.1M $-302.2M +82.7% 0.00% $-545.8M $-582.5M +7.6%
FY 2023 $402.9M -22.6% $-104.1M $-3,278.2M -984.8% $-7.07 0.00% $-557.5M $-566.8M +2.7%
FY 2024 $297.1M -26.2% $80.9M $-657.3M +80.0% $-8.79 -24.3% 0.00% $-281.9M $-285.4M +49.6%
FY 2025 $269.0M -9.5% $79.5M $-598.1M +9.0% $-5.56 +36.7% 0.00% $-165.8M $-176.6M +38.1%
FY 2026 $284.6M +5.8% $69.7M $-262.9M +56.0% $-0.88 +84.2% 0.00% $-63.8M $-69.1M +60.8%
$

Valuation

Market Price $0.98
Market Cap $409.41M
Enterprise Value $278.08M
P/E Ratio N/A
P/B Ratio 0.59
FCF Yield -16.89%
Dividend Yield N/A
Shares Outstanding 422,068,200
%

Profitability & Margins

Gross Margin 24.48%
Operating Margin -56.80%
Net Margin -92.38%
Return on Equity (ROE) -37.69%
Return on Assets (ROA) -23.50%
Asset Turnover 0.25x
Revenue 3-Yr CAGR -10.94%
🛡️

Financial Health & Liquidity

Current Ratio 3.34
Cash Ratio 2.30
Debt / Equity 0.335
Debt / Assets 0.209
Cash & Equivalents $364.68M
Total Debt $233.36M
Book Value / Share $1.65
💧

Cash Flow Efficiency

Operating Cash Flow -$63.81M
Capital Expenditures (CapEx) $5.33M
Free Cash Flow -$69.14M
OCF / Revenue -22.42%
FCF / Revenue -24.29%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.88
EPS (Basic) $-0.88
Dividends / Share N/A
Book Value / Share $1.65
EPS YoY Growth 84.17%
🏛️

Balance Sheet (FY 2026)

Total Assets $1.12B
Total Liabilities $421.14M
Stockholders' Equity $697.59M
Current Assets $529.47M
Current Liabilities $158.44M